Skip to main content

The Business of Selling Hope

This is the third post to be loosely inspired by our recent trip to the Coalition for Compassionate Care of California (see here and here for the first two).

At the meeting, someone stood up and talked about how some hospitals will pander to patients who are intent on finding a cure, saying they are in the business of selling hope.  One could argue they are in the business of selling fear, but it seems they are two sides to a coin.

Let's take, just for example, the Cancer Treatment Centers of America.  I know nothing about this company, really, other than their advertising.  But here are some examples of their advertising:




Palliative care is not one of the 21 services listed on the Cancer Treatment Centers of America Treatments page.  Thanks to some further digging by Eric Widera, try sticking "advance care planning," or "advance directive," or "POLST" into their search box.  Nada, nothing, zilch.

And hospice?  Here is what they say about hospice:
Hospice is not a treatment option for cancer, but rather a means to improve the quality of life of cancer patients, and patients with terminal illnesses.
Hospice is not a treatment option for cancer?  For most advanced cancers, treatment is directed at palliating the symptoms and possibly prolonging life by small amounts of time.  Hospice certainly is a cancer treatment that accomplishes the former, and maybe the latter.

So here is the question - are companies such as this meeting consumer demand, or creating markets for themselves?  It's probably some of both - with both patients and physicians conspiring together in reinforcing fantasies of hope.  And it may be very profitable for companies like the Cancer Treatment Centers of America to meet and amplify consumer demand.

This reminds me of the recent study that showed patients with incurable cancer who thought chemotherapy would cure them rated their doctor less favorably than patients who believed chemotherapy might cure them.

So sure, it may make patients more satisfied in the short term.  We can sell this type of hope.  Maybe it's even easier, in the short term.  But at what cost?  Will patients and families look back and say "thank you" when their hopes are not fulfilled?  Or will it end in the ICU...

James Tulsky wrote a paper called, "Hope and Hubris" in the Journal of Palliative Medicine a decade ago.  In it, he expounds on Webster's two interpretations of hope: the first based on trust; the second on "desire accompanied by expectation of or belief in fulfillment."  The second type of hope requires that expectations be fulfilled, and is unlikely to be met by offering a cure to patients with incurable conditions.

However, even for patients who have a faith-based belief in cure despite the communication of realistic prognostic information, we can build and support hope, in the first sense, by building trust.  As he says in the conclusion of the article:
The physician who spends time with the patient, is honest but compassionate, and expresses empathy offers a hopeful presence even in the face of bad news.
Now that's the type of hope companies should be selling.

by: Alex Smith

Comments

Marian Grant, NP said…
These latest posts have been terrific. I can't tell you what a public service they perform. Please keep up this great work!
Lovely post Alex. By way of my childhood friend Lance - who passed away in 2010 after a 4 year struggle with pancreatic cancer - I can offer some color on the CTC's of America experience in selecting patients, and the search for 'hope' around the time of diagnosis. It was long ago, but I remember clearly the desperate hunt for alternatives to, of all places, Memorial Sloan Kettering (!). There was a physician in Mexico who promised a therapeutic agent which was 'highly effective in metastatic pancreatic cancer,' and he would send by mail for a fee. (I talked them out of that one!) Then there was the discussion around the CTC's of America. Their intake person spoke with Lance's wife, were eager to have them visit Dallas (?, maybe Phoenix?), but when the finances of the family were found to be as bleak as they were, the interest waned. Apparently the entry point to their services is an initial payment, after which some services are covered by insurance, but not all - especially travel. That's where the conversations ended. But the sell to the family was decidedly holistic, that much I remember.

In the end, MSD did right by my friend, but I have to admit their palliative chops were lacking in the end. The PC fellow was wonderful, but had no backing from the interventional and oncology teams, and she confessed as much to me on one of my multiple trips to/from NYC from SF in the final months.

Even in my current world - post-acute and long-term care - I often face pushback from operators and other physicians about the financial viability of the PC services that we are developing. So no surprise that pall/hospice care is left out of those most concerned with billable services.

Keep it up!

www.snfdocs.com
Hope & patience is most important factor in business
santa said…
Generally, it is believed that the cancer arises, or a pre existing cancer is encouraged, during the process of repairing the trauma, rather than the cancer being caused directly by the trauma. However, repeated injuries to the same tissues might promote excessive cell proliferation, which could then increase the odds of a cancerous mutation. There is no evidence that inflammation itself causes cancer. Thanks.
Regards,
creative bioscience green coffee

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Opening the Black Box of LTACs: Podcast with Anil Makam

What happens in Long Term Acute Care Hospitals, or LTACs (pronounced L-tacs)?  I've never been in one.  I've sent patients to them - usually patients with long ICU stays, chronically critically ill, with a gastric feeding tube and a trach for ventilator support.  For those patients, the goals (usually as articulated by the family) are based on a hope for recovery of function and a return home.

And yet we learn some surprising things from Anil Makam, Assistant Professor of Medicine at UCSF.  In his JAGS study of about 14,000 patients admitted to LTACHs, the average patient spent two thirds of his or her remaining life in an institutional settings (including hospitals, LTACs and skilled nursing facilities).  One third died in an LTAC, never returning home.

So you would think with this population of older people with serious illness and a shorter prognosis than many cancers, we would have robust geriatrics and palliative care in LTACs?  Right? Wrong.

3% were seen by a geriatrici…

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…